Soleus Capital Management, L.P. Celcuity Inc. Transaction History
Soleus Capital Management, L.P.
- $1.29 Billion
- Q2 2025
A detailed history of Soleus Capital Management, L.P. transactions in Celcuity Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 3,011,818 shares of CELC stock, worth $151 Million. This represents 3.12% of its overall portfolio holdings.
Number of Shares
3,011,818
Previous 2,574,122
17.0%
Holding current value
$151 Million
Previous $26 Million
54.5%
% of portfolio
3.12%
Previous 2.15%
Shares
16 transactions
Others Institutions Holding CELC
# of Institutions
100Shares Held
31.6MCall Options Held
40.2KPut Options Held
21.5K-
Baker Bros. Advisors LP New York, NY5.45MShares$273 Million0.74% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$174 Million1.82% of portfolio
-
Nea Management Company, LLC Timonium, MD2.29MShares$115 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$83.5 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY1.63MShares$81.8 Million0.96% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $748M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...